Low-FODMAP Bread May Reduce Symptoms of IBS

This article originally appeared here.
Share this content:
Low-FODMAP Bread May Reduce Symptoms of IBS
Low-FODMAP Bread May Reduce Symptoms of IBS

FRIDAY, July 22, 2016 (HealthDay News) -- Rye bread low in fermentable oligo-, di-, monosaccharides and polyols (FODMAPs) can help control symptoms of irritable bowel syndrome (IBS), according to a study published online July 15 in Alimentary Pharmacology and Therapeutics.

Reijo Laatikainen, M.D., from the University of Helsinki, and colleagues conducted a randomized double-blind trial involving 87 subjects with IBS. For four weeks, patients were given regular rye bread and low-FODMAP rye bread. Symptoms were measured and quality of life monitored

The researchers found that, compared with baseline, dietary fiber intake increased during both study periods. Flatulence, abdominal pain, cramps, and stomach rumbling were milder in the low-FODMAP rye bread group (P = 0.04, 0.049, 0.01, and 0.001, respectively). The mean of the visual analogue scale measurements was favorable for low-FODMAP bread; no differences were seen for the IBS symptom severity scoring system (IBS-SSS) or quality of life. During the low-FODMAP bread period the area under the curve of breath hydrogen values was significantly lower (median, 52.9 versus 72.6; P = 0.01).

"Low-FODMAP rye bread helps IBS patients to control their symptoms and reduces gastrointestinal gas accumulation," the authors write. "However, replacing regular rye bread [with] low-FODMAP bread without concomitant broader dietary changes does not improve quality of life or IBS-SSS."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »